mitomycin has been researched along with Exfoliation Glaucoma in 34 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 8.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 8.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 8.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 7.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 7.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
| "To compare the long-term effects of low-dosage mitomycin C (MMC) in both deep sclerectomy (DSMMC) and trabeculectomy (TPMMC) on intraocular pressure (IOP)." | 5.13 | Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. ( Casuccio, A; Cillino, G; Cillino, S; Di Pace, F; Lodato, G, 2008) |
| "To compare the efficacy and safety of primary Ahmed valve implantation (AVI) and primary trabeculectomy with mitomycin C (MMC) in patients with pseudophakic exfoliative glaucoma (XFG)." | 4.31 | Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma. ( Ahn, HB; Hwang, SY; Jin, SW, 2023) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 4.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "To compare the short-term outcomes of combined phaco-emulsification with posterior chamber intra-ocular lens and mitomycin augmented trabeculectomy in patients with pseudo-exfoliation glaucoma (PXFG) versus primary open-angle glaucoma (POAG)." | 4.12 | Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma. ( Krishna, SM; Kumar, MR; Odayappan, A; Puthuran, GV; Senthilkumar, VA; Uduman, MS; Wijesinghe, HK, 2022) |
| "Consecutive prospective case series study to examine the 6-month outcome of 106 eyes [primary open-angle glaucoma (OAG), exfoliation glaucoma (XFG), and inflammatory glaucoma (ING)] that underwent TLE with mitomycin C performed by a single surgeon from September 2009 to September 2010 at Tokyo University Hospital." | 3.81 | Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon. ( Aihara, M; Aoyama, Y; Murata, H, 2015) |
| "The medical records of patients with primary open-angle glaucoma or exfoliation glaucoma who had trabeculectomy with mitomycin-C were reviewed." | 3.78 | Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C. ( Awai-Kasaoka, N; Inatani, M; Inoue, T; Kawaguchi, A; Ogata-Iwao, M; Takihara, Y; Tanihara, H, 2012) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG) patients." | 3.77 | Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. ( Ollikainen, ML; Puustjärvi, TJ; Rekonen, PK; Teräsvirta, ME; Uusitalo, HM, 2011) |
| "Pre- and postsurgical IOPs at 6 months were compared in one eye of each of 789 subjects with primary open-angle glaucoma, pseudoexfoliation glaucoma, or ocular hypertension who underwent trabeculectomy with adjunctive mitomycin C alone (Lectomy-MMC) (n = 145), phaco-viscocanalostomy (Phaco-VCS) (n = 320), phaco-trabeculotomy ab externo (Phaco-lotomy) (n = 116), or phacoemulsification aspiration and intraocular lens implantation alone (PEA+IOL) (n = 208)." | 3.77 | Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy. ( Chihara, E; Hayashi, K, 2011) |
| "To investigate the efficacy and safety of mitomycin C (MMC)-augmented deep sclerectomy with implant (DSCI) in patients with primary open-angle glaucoma (POAG) and exfoliation glaucoma (ExG)." | 3.76 | Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. ( Ollikainen, M; Puustjärvi, T; Rekonen, P; Teräsvirta, M; Uusitalo, H, 2010) |
| "Mitomycin C was used in 25 procedures (83." | 2.77 | CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study. ( Assia, EI; Degani, J; Geffen, N; Ton, Y, 2012) |
| "Low postoperative complications were recorded." | 1.56 | Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma. ( Kalogianni, E; Kozobolis, V; Sideroudi, H, 2020) |
| "Mean intraocular pressure was significantly reduced from 21." | 1.51 | One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. ( Arrieta-Los Santos, A; Chacón-González, M; Del Río Mayor, JL; Ibáñez-Muñoz, A; Lizuain-Abadía, ME; Rúa-Galisteo, O; Soto-Biforcos, VS, 2019) |
| "To report the 5-year incidence of visual impairment after mitomycin C-augmented trabeculectomy (MMC trabeculectomy) and the risk factors for visual impairment." | 1.43 | Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C. ( Araie, M; Chiba, T; Kashiwagi, K; Kogure, S; Kuwayama, Y; Mabuchi, F; Yamamoto, T, 2016) |
| "Filtering blebs with various types of glaucoma were examined using Stratus OCT." | 1.36 | Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap. ( Baba, T; Hirooka, K; Shiraga, F; Takagishi, M; Takenaka, H, 2010) |
| "We report a case of suprachoroidal hemorrhage following removal of a releasable suture after combined phacoemulsification-trabeculectomy." | 1.34 | Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy. ( Eong, KG; Prashanth, S; Raman, GV; Sathyan, P; Singh, G, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 7 (20.59) | 29.6817 |
| 2010's | 20 (58.82) | 24.3611 |
| 2020's | 5 (14.71) | 2.80 |
| Authors | Studies |
|---|---|
| Tekcan, H | 1 |
| Mangan, MS | 1 |
| Alpogan, O | 1 |
| Imamoglu, S | 1 |
| Kose, AO | 1 |
| Ercalık, NY | 1 |
| Senthilkumar, VA | 1 |
| Kumar, MR | 1 |
| Wijesinghe, HK | 1 |
| Uduman, MS | 1 |
| Krishna, SM | 1 |
| Odayappan, A | 1 |
| Puthuran, GV | 1 |
| Hwang, SY | 1 |
| Ahn, HB | 1 |
| Jin, SW | 1 |
| Cutolo, CA | 1 |
| Iester, M | 1 |
| Bagnis, A | 1 |
| Bonzano, C | 1 |
| Negri, L | 1 |
| Olivari, S | 1 |
| Cappelli, F | 1 |
| Testa, V | 1 |
| Sindaco, D | 1 |
| Pizzorno, C | 1 |
| Scotto, R | 1 |
| Saccheggiani, M | 1 |
| Traverso, CE | 1 |
| Vahedian, Z | 1 |
| Mafi, M | 1 |
| Fakhraie, G | 1 |
| Zarei, R | 1 |
| Eslami, Y | 1 |
| Ghadimi, H | 1 |
| Mohebbi, M | 1 |
| Gizzi, C | 1 |
| Mohamed-Noriega, J | 1 |
| Elkarmouty, A | 1 |
| Scott, A | 1 |
| Ibáñez-Muñoz, A | 1 |
| Soto-Biforcos, VS | 1 |
| Chacón-González, M | 1 |
| Rúa-Galisteo, O | 1 |
| Arrieta-Los Santos, A | 1 |
| Lizuain-Abadía, ME | 1 |
| Del Río Mayor, JL | 1 |
| Paletta Guedes, RA | 1 |
| Gravina, DM | 1 |
| Paletta Guedes, VM | 1 |
| Chaoubah, A | 1 |
| Kozobolis, V | 1 |
| Kalogianni, E | 1 |
| Sideroudi, H | 1 |
| Sorkhabi, R | 1 |
| Najafzadeh, F | 1 |
| Sadeghi, A | 1 |
| Ahoor, M | 1 |
| Mahdavifard, A | 1 |
| Ogata-Iwao, M | 2 |
| Inatani, M | 2 |
| Takihara, Y | 2 |
| Inoue, T | 2 |
| Iwao, K | 1 |
| Tanihara, H | 2 |
| Brüggemann, A | 1 |
| Despouy, JT | 1 |
| Wegent, A | 1 |
| Müller, M | 1 |
| Akkan, JU | 1 |
| Cilsim, S | 1 |
| Aoyama, Y | 1 |
| Murata, H | 1 |
| Aihara, M | 1 |
| Lim, SH | 1 |
| Cha, SC | 1 |
| Panarelli, JF | 1 |
| Banitt, MR | 1 |
| Gedde, SJ | 1 |
| Shi, W | 1 |
| Schiffman, JC | 1 |
| Feuer, WJ | 1 |
| Cillino, S | 2 |
| Casuccio, A | 2 |
| Di Pace, F | 2 |
| Cagini, C | 1 |
| Ferraro, LL | 1 |
| Cillino, G | 2 |
| Kashiwagi, K | 1 |
| Kogure, S | 1 |
| Mabuchi, F | 1 |
| Chiba, T | 1 |
| Yamamoto, T | 1 |
| Kuwayama, Y | 1 |
| Araie, M | 1 |
| Hirooka, K | 1 |
| Takagishi, M | 1 |
| Baba, T | 1 |
| Takenaka, H | 1 |
| Shiraga, F | 1 |
| Chihara, E | 2 |
| Okazaki, K | 1 |
| Takahashi, H | 1 |
| Shoji, T | 1 |
| Adachi, H | 1 |
| Hayashi, K | 2 |
| Ollikainen, M | 1 |
| Puustjärvi, T | 1 |
| Rekonen, P | 1 |
| Uusitalo, H | 1 |
| Teräsvirta, M | 1 |
| Ollikainen, ML | 1 |
| Puustjärvi, TJ | 1 |
| Rekonen, PK | 1 |
| Uusitalo, HM | 1 |
| Teräsvirta, ME | 1 |
| Geffen, N | 1 |
| Ton, Y | 1 |
| Degani, J | 1 |
| Assia, EI | 1 |
| Nilforushan, N | 1 |
| Yadgari, M | 1 |
| Kish, SK | 1 |
| Nassiri, N | 1 |
| Awai-Kasaoka, N | 1 |
| Kawaguchi, A | 1 |
| Sacu, S | 1 |
| Rainer, G | 1 |
| Findl, O | 1 |
| Georgopoulos, M | 1 |
| Vass, C | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Zalish, M | 1 |
| Aykan, U | 1 |
| Bilge, AH | 1 |
| Akin, T | 1 |
| Certel, I | 1 |
| Bayer, A | 1 |
| Sathyan, P | 2 |
| Singh, G | 1 |
| Eong, KG | 1 |
| Raman, GV | 1 |
| Prashanth, S | 1 |
| Li, G | 1 |
| O'Hearn, T | 1 |
| Yiu, S | 1 |
| Francis, BA | 1 |
| Lodato, G | 1 |
| Greenfield, DS | 1 |
| Samuelson, TW | 1 |
1 review available for mitomycin and Exfoliation Glaucoma
| Article | Year |
|---|---|
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Exfoliation Syndrome; Fluorouracil; Glaucoma; Humans; Lenses, Intraoc | 1995 |
7 trials available for mitomycin and Exfoliation Glaucoma
| Article | Year |
|---|---|
Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Double-Blind Metho | 2017 |
Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Co | 2015 |
Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Topics: Absorbable Implants; Adult; Aged; Alkylating Agents; Collagen; Exfoliation Syndrome; Female; Follow- | 2016 |
CO2 laser-assisted sclerectomy surgery, part II: multicenter clinical preliminary study.
Topics: Adult; Alkylating Agents; Exfoliation Syndrome; Female; Filtering Surgery; Glaucoma, Open-Angle; Hum | 2012 |
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Topics: Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemothe | 2012 |
Laser suture lysis or releasable sutures after trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Aqueous Humor; Exfoliation Syndrome; Female; Glau | 2007 |
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
Topics: Aged; Dose-Response Relationship, Drug; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, O | 2008 |
26 other studies available for mitomycin and Exfoliation Glaucoma
| Article | Year |
|---|---|
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul | 2022 |
Short-term surgical outcomes of twin-site combined phaco-emulsification and mitomycin-C augmented trabeculectomy in pseudo-exfoliation glaucoma versus primary open-angle glaucoma.
Topics: Aged; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Mitomyc | 2022 |
Comparison between primary Ahmed valve implantation and primary trabeculectomy with mitomycin C in pseudophakic patients with exfoliative glaucoma.
Topics: Exfoliation Syndrome; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Mitomycin; Retrospe | 2023 |
Early Postoperative Intraocular Pressure is Associated With Better Pressure Control After XEN Implantation.
Topics: Adult; Aged; Exfoliation Syndrome; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; | 2020 |
Trabeculectomy Following Failed Ab Interno Gelatin Microstent: Case Series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; | 2018 |
One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Conjunctiva; Exfoliation Syndro | 2019 |
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Collagen; Exfoliation Syndrome; Female; Glauco | 2019 |
Penetrating deep sclerectomy in primary open-angle and pseudoexfoliative glaucoma.
Topics: Aged; Aged, 80 and over; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pre | 2020 |
Corneal biomechanical changes after trabeculectomy with mitomycin C in primary open-angle glaucoma and pseudoexfoliation glaucoma.
Topics: Adult; Aged; Biomechanical Phenomena; Cornea; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hu | 2019 |
A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C.
Topics: Aged; Alkylating Agents; Cataract; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intra | 2013 |
Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Catheterization; Exfolia | 2013 |
Targeting a low-teen intraocular pressure by trabeculectomy with a fornix-based conjunctival flap: continuous Japanese case series by a single surgeon.
Topics: Adult; Aged; Alkylating Agents; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Hum | 2015 |
Long-term Outcomes of Mitomycin-C Trabeculectomy in Exfoliative Glaucoma Versus Primary Open-Angle Glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Conjunctiva; Exfoliation Sy | 2017 |
A Retrospective Comparison of Primary Baerveldt Implantation versus Trabeculectomy with Mitomycin C.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Syndrome; F | 2016 |
Change in visual acuity and associated risk factors after trabeculectomy with adjunctive mitomycin C.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Exfoliatio | 2016 |
Stratus optical coherence tomography study of filtering blebs after primary trabeculectomy with a fornix-based conjunctival flap.
Topics: Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Exfoliation Syndrome; Female; Glaucoma; Glauco | 2010 |
Modified deep sclerectomy (D-lectomy MMC) for primary open-angle glaucoma: preliminary results.
Topics: Aged; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Int | 2009 |
Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Topics: Absorbable Implants; Aged; Anterior Chamber; Choroid Diseases; Collagen; Drug Implants; Exfoliation | 2010 |
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Topics: Aged; Alkylating Agents; Combined Modality Therapy; Exfoliation Syndrome; Female; Follow-Up Studies; | 2011 |
Different modes of intraocular pressure reduction after three different nonfiltering surgeries and trabeculectomy.
Topics: Adult; Aged; Aged, 80 and over; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pres | 2011 |
Impact of phacoemulsification on failure of trabeculectomy with mitomycin-C.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Combined Modality Therapy; Exfoliation Synd | 2012 |
Correlation between the early morphological appearance of filtering blebs and outcome of trabeculectomy with mitomycin C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Fem | 2003 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Choroid Hemorrhage; Combined Modality Therapy; Exfoliation Syndro | 2007 |
Amniotic membrane transplantation for intraoperative conjunctival repair during trabeculectomy with mitomycin C.
Topics: Aged; Aged, 80 and over; Amnion; Combined Modality Therapy; Conjunctiva; Exfoliation Syndrome; Eye I | 2007 |
Bleb-related ocular infection.
Topics: Aged; Anti-Bacterial Agents; Aqueous Humor; Drug Therapy, Combination; Endophthalmitis; Exfoliation | 1998 |